CEACAM5 and carcinoma: Examination of blood samples for increased levels of serum biomarkers from tumour cells are commonly used in this step, e.g., carcinoma antigen 15-3 (CA 15.3), Carcinoma antigen 27.29 (CA27.29), Carcinoembryonic antigen (CEA) and others [2].